Mercer Global Advisors »

Lyell Immunopharma shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $59k 40k 1.45
2024-03-31 $95k 43k 2.22

More positions owned by Mercer Global Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Intl Moment (IMTM)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Shrt Nat Mun Etf (SUB)
Eli Lilly & Co. (LLY)

View all positions for Mercer Global Advisors

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
OrbiMed Advisors
Alphabet
Geode Capital Management
State Street Corporation
Sc China Holding
MIC Capital Management UK
Opaleye Management

View all funds holding Lyell Immunopharma